KalVista Pharmaceuticals (KALV) Prices 4M Share Common Offering at $17/Sh

September 6, 2018 9:17 AM EDT Send to a Friend
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login